LogicMark, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
LogicMark, Inc. (LGMK) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$71.81 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-19
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$1.46M, a 128.13% decline year-over-year.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $5.18M.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$1.35M, a 148.16% decline year-over-year.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $2.80M, a 1454.20% increase year-over-year.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$239.43K.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$2.59M.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$638.94K.
- LogicMark, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$5.22M, a 167.61% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$71.81K 10-Q · filed 2026-08-19 | ||||
| 2026-03-31 | -$1.46M 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | -$239.43K 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $310.64K 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | $1.21M 10-Q · filed 2026-08-19 | ||||
| 2025-03-31 | $5.18M 10-Q · filed 2026-05-15 | ||||
| 2024-12-31 | -$2.59M 10-K · filed 2026-03-27 | ||||
| 2024-09-30 | -$812.33K 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | -$3.44M 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | -$1.35M 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | -$638.94K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$294.12K 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $672.62K 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | $2.80M 10-Q · filed 2024-05-15 | ||||
| 2022-12-31 | -$5.22M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | -$2.87M 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$1.05M 10-Q · filed 2023-08-11 | ||||
| 2022-03-31 | $180.46K 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | $7.72M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $11.69M 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$1.14M 10-Q · filed 2022-08-12 | -$1.14M 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $4.13M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $2.80M 10-K · filed 2022-04-15 | ||||
| 2020-09-30 | $505.28K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | -$224.87K 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | -$148.37K 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | $122.74K 10-K · filed 2021-04-15 | ||||
| 2019-09-30 | $2.75M 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | -$120.97K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |